Recombinant forms of the dengue 2 virus NS3 protease linked to a 40-residue co-factor, corresponding to part of NS2B, have been expressed in Escherichia coli and shown to be active against para-nitroanilide substrates comprising the P6-P1 residues of four substrate cleavage sequences. The enzyme is inactive alone or after the addition of a putative 13-residue co-factor peptide but is active when fused to the 40-residue co-factor, by either a cleavable or a noncleavable glycine linker. The NS4B/NS5 cleavage site was processed most readily, with optimal processing conditions being pH 9, I = 10 mm, 1 mm CHAPS, 20% glycerol. A longer 10-residue peptide corresponding to the NS2B/NS3 cleavage site (P6-P4') was a poorer substrate than the hexapept...
Dengue virus type 2 NS3, a multifunctional protein, has a serine protease domain (NS3pro) that requi...
[[abstract]]Dengue virus (DENV) causes disease globally with an estimated 25 to 100 million new infe...
The discovery of potent therapeutic compounds against dengue virus is urgently needed. The NS2B-NS3 ...
Dengue Virus (DENV) infection is responsible for the world's most significant insect-borne viral dis...
AbstractA series of 45 peptide inhibitors was designed, synthesized, and evaluated against the NS2B–...
The mosquito-transmitted dengue virus (DENV) infects millions of people in tropical and subtropical ...
A recombinant dengue 2 virus NS2B-NS3 protease (NS means non-structural virus protein) was compared ...
A recombinant dengue 2 virus NS2B-NS3 protease (NS means non-structural virus protein) was compared ...
Dengue Virus (DENV) is the most prevalent global arbovirus, yet despite an increasing burden to heal...
Dengue virus (DENV) infection affects millions of people in the world. DENV, the causal agent is a m...
Regulated proteolysis of the polyprotein precursor by the NS2B– NS3 protease is required for the pro...
Dengue virus (DENV), transmitted predominantly in tropical and subtropical regions by the mosquito A...
The protein-ligand binding interactions studies were carried out by performing dockings of the ligan...
Background; Global resurgence of dengue virus infections in many of the tropical and subtropical cou...
Regulated proteolysis by the two-component NS2B/NS3 protease of dengue virus is essential for virus ...
Dengue virus type 2 NS3, a multifunctional protein, has a serine protease domain (NS3pro) that requi...
[[abstract]]Dengue virus (DENV) causes disease globally with an estimated 25 to 100 million new infe...
The discovery of potent therapeutic compounds against dengue virus is urgently needed. The NS2B-NS3 ...
Dengue Virus (DENV) infection is responsible for the world's most significant insect-borne viral dis...
AbstractA series of 45 peptide inhibitors was designed, synthesized, and evaluated against the NS2B–...
The mosquito-transmitted dengue virus (DENV) infects millions of people in tropical and subtropical ...
A recombinant dengue 2 virus NS2B-NS3 protease (NS means non-structural virus protein) was compared ...
A recombinant dengue 2 virus NS2B-NS3 protease (NS means non-structural virus protein) was compared ...
Dengue Virus (DENV) is the most prevalent global arbovirus, yet despite an increasing burden to heal...
Dengue virus (DENV) infection affects millions of people in the world. DENV, the causal agent is a m...
Regulated proteolysis of the polyprotein precursor by the NS2B– NS3 protease is required for the pro...
Dengue virus (DENV), transmitted predominantly in tropical and subtropical regions by the mosquito A...
The protein-ligand binding interactions studies were carried out by performing dockings of the ligan...
Background; Global resurgence of dengue virus infections in many of the tropical and subtropical cou...
Regulated proteolysis by the two-component NS2B/NS3 protease of dengue virus is essential for virus ...
Dengue virus type 2 NS3, a multifunctional protein, has a serine protease domain (NS3pro) that requi...
[[abstract]]Dengue virus (DENV) causes disease globally with an estimated 25 to 100 million new infe...
The discovery of potent therapeutic compounds against dengue virus is urgently needed. The NS2B-NS3 ...